HSV-2 and HIV: consequences of an endemic opportunistic infection.
Wald
A
A
University of Washington, School of Medicine, Seattle, WA.
Schacker
T
T
Corey
L
L
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D004279:DNA, Viral / Q000032:analysis*; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000276:immunology / Q000635:transmission*; D006558:Herpes Genitalis / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D018258:Herpesvirus 2, Human; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D015854:Up-Regulation; D017201:Virus Shedding
D000998:Antiviral Agents; D004279:DNA, Viral; D000212:Acyclovir